Imatinib: Aggressive systemic mastocytosis medication

Indianpharma31 Mar, 2022Health

Healthcare professionals recommend using the drug Imatinib for treating patients with chronic myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, dermatofibrosarcoma protuberans, gastrointestinal stromal tumors, etc. The active ingredient in the medicine is Imatinib mesylate, and inactive ingredients are colloidal silicon dioxide, crospovidone, hydroxypropyl methylcellulose, magnesium stearate, and microcrystalline cellulose. Imatinib mesylate price is economical, and it is easily available with several generic medicine suppliers, for more queries, dial 18008891064.

Recent Profiles

Cash For Homes Utah

Cash For Homes Utah

View Profile

changdiamond

Changdiamond

View Profile

Carton de déménagement Lille

Carton De Déménagement Lille

View Profile

TPC Windows and Siding - Watertown CT

Tpc Windows And Siding - Watertown Ct

View Profile

TY Health Insurance Brokerage

Ty Health Insurance Brokerage

View Profile

Vn88 Today

Vn88 Today

View Profile

Weave Sutra

Weave Sutra

View Profile

Alina Bailey

Alina Bailey

View Profile

Harvest Chocolate

Harvest Chocolate

View Profile

Abigail Addison

Abigail Addison

View Profile